Automated Author ProfileMeeks, Karlijn A. C.
National Institutes of Health
Meeks, Karlijn A. C.
Current S-Index
Sum of Dataset Indices for all datasets
Average Dataset Index per Dataset
Average Dataset Index per dataset
Total Datasets
Total datasets for this author
Average FAIR Score
Average FAIR Score per dataset
Total Citations
Total citations to the author's datasets
Total Mentions
Total mentions of the author's datasets
S-Index Interpretation
The S-Index (Sharing Index) is a comprehensive metric that represents the cumulative impact of all your datasets. It is calculated as the sum of Dataset Index scores across all your claimed datasets.
What it means:
- A higher S-index indicates greater overall impact of your datasets relative to typical datasets in their fields of research
- The S-Index grows as you add more datasets or as existing datasets gain more citations and mentions
- It provides a single number to track your research data impact over time
Current S-Index: 1.7 (sum of 2 datasets Dataset Index scores)
More information here.
S-Index Over Time
Cumulative Citations Over Time
Cumulative Mentions Over Time
Datasets
Additional file 1: Table S1: Number of samples per cohort and per obesity-related cytokine and hormone. Table S2: Total number of genome-wide significant (P-value < 5×10-8) loci detected in the discovery cohort, number of novel loci, and number of loci replicated in African Americans per trait and per model. Table S3: Variants at genome-wide significance of P-value < 5×10-8 with low MAF (<5%) before and after removal of high leverage points based on Cook's distance. Table S4: Variants at genome-wide significance of P-value < 5×10-8 per adipocytokine/hormone for the meta-analysis of discovery and replication cohorts combined. Table S5: Genome-wide significant loci from base model analyses with moderate or strong evidence for colocalization with eQTL data from GTEx. Table S6: Variants at genome-wide significance of P-value < 5×10-8 per adipocytokine/hormone for men only. Table S7: Variants at genome-wide significance of P-value < 5×10-8 per adipocytokine/hormone for women only. Table S8: Variants at genome-wide significance of P-value < 5×10-8 per adipocytokine/hormone for lean (BMI < 25.0 kg/m2) individuals only. Table S9: Variants at genome-wide significance of P-value < 5×10-8 per adipocytokine/hormone for overweight (BMI ≥ 25.0 kg/m2) individuals only. Table S10: Variants at genome-wide significance of P-value < 5×10-8 per adipocytokine/hormone for T2D controls only. Table S11: Variants at genome-wide significance of P-value < 5×10-8 per adipocytokine/hormone for T2D cases only. Table S12: Canonical pathways for genes annotated to genome-wide significant and suggestive loci in the base model
Authors
- Meeks, Karlijn A. C. ;
- Bentley, Amy R. ;
- Gouveia, Mateus H. ;
- Chen, Guanjie ;
- Zhou, Jie ;
- Lei, Lin ;
- Adeyemo, Adebowale A. ;
- Doumatey, Ayo P. ;
- Rotimi, Charles N.
Additional file 1: Table S1: Number of samples per cohort and per obesity-related cytokine and hormone. Table S2: Total number of genome-wide significant (P-value < 5×10-8) loci detected in the discovery cohort, number of novel loci, and number of loci replicated in African Americans per trait and per model. Table S3: Variants at genome-wide significance of P-value < 5×10-8 with low MAF (<5%) before and after removal of high leverage points based on Cook's distance. Table S4: Variants at genome-wide significance of P-value < 5×10-8 per adipocytokine/hormone for the meta-analysis of discovery and replication cohorts combined. Table S5: Genome-wide significant loci from base model analyses with moderate or strong evidence for colocalization with eQTL data from GTEx. Table S6: Variants at genome-wide significance of P-value < 5×10-8 per adipocytokine/hormone for men only. Table S7: Variants at genome-wide significance of P-value < 5×10-8 per adipocytokine/hormone for women only. Table S8: Variants at genome-wide significance of P-value < 5×10-8 per adipocytokine/hormone for lean (BMI < 25.0 kg/m2) individuals only. Table S9: Variants at genome-wide significance of P-value < 5×10-8 per adipocytokine/hormone for overweight (BMI ≥ 25.0 kg/m2) individuals only. Table S10: Variants at genome-wide significance of P-value < 5×10-8 per adipocytokine/hormone for T2D controls only. Table S11: Variants at genome-wide significance of P-value < 5×10-8 per adipocytokine/hormone for T2D cases only. Table S12: Canonical pathways for genes annotated to genome-wide significant and suggestive loci in the base model
Authors
- Meeks, Karlijn A. C. ;
- Bentley, Amy R. ;
- Gouveia, Mateus H. ;
- Chen, Guanjie ;
- Zhou, Jie ;
- Lei, Lin ;
- Adeyemo, Adebowale A. ;
- Doumatey, Ayo P. ;
- Rotimi, Charles N.